Kangji Medical Holdings Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Kangji Medical Holdings kazanç ve gelirinin sırasıyla yıllık 12.1% ve 14.2% oranında artması tahmin edilirken, EPS'nin yıllık 11.7% oranında büyümesi bekleniyor.

Anahtar bilgiler

12.1%

Kazanç büyüme oranı

11.7%

EPS büyüme oranı

Medical Equipment kazanç büyümesi	14.2%
Gelir büyüme oranı	14.2%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	21 Nov 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

DB:50J - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	1,393	730	N/A	N/A	1
12/31/2025	1,210	637	N/A	N/A	2
12/31/2024	1,042	575	N/A	N/A	2
6/30/2024	981	534	373	472	N/A
3/31/2024	953	519	353	446	N/A
12/31/2023	926	504	333	420	N/A
9/30/2023	892	540	312	390	N/A
6/30/2023	858	576	291	360	N/A
3/31/2023	822	528	267	340	N/A
12/31/2022	786	479	242	319	N/A
9/30/2022	745	447	261	326	N/A
6/30/2022	704	415	281	332	N/A
3/31/2022	697	436	343	384	N/A
12/31/2021	690	457	405	436	N/A
9/30/2021	654	413	379	405	N/A
6/30/2021	617	369	353	374	N/A
3/31/2021	564	310	278	298	N/A
12/31/2020	511	250	203	221	N/A
9/30/2020	506	227	246	261	N/A
6/30/2020	500	204	290	301	N/A
3/31/2020	502	205	303	313	N/A
12/31/2019	503	206	316	326	N/A
12/31/2018	354	147	189	205	N/A
12/31/2017	248	118	N/A	143	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 50J 'nin tahmini kazanç büyümesi (yıllık 12.1% ) tasarruf oranının ( 1% ) üzerindedir.

Kazançlar ve Piyasa: 50J şirketinin kazançlarının (yıllık 12.1% ) German pazarından (yıllık 21.1% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 50J şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 50J şirketinin gelirinin (yıllık 14.2% ) German pazarından (yıllık 5.7% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 50J şirketinin gelirinin (yıllık 14.2% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 50J 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Kangji Medical Holdings Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023)

Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024

New minor risk - Share price stability

Kangji Medical Holdings Limited Approves Special Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024

Upcoming dividend of CN¥1.40 per share

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022)

Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023

New major risk - Dividend sustainability

Dividend of CN¥1.40 announced

Kangji Medical Holdings Limited, Annual General Meeting, May 27, 2024

New minor risk - Share price stability

Kangji Medical Holdings Limited Announces CFO Changes

First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022)

Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023

Full year 2022 earnings released

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021)

Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021, Payment date is 08 July 2022

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.17 per share

Kangji Medical Holdings Limited Announces Executive Changes

Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020)

Less than half of directors are independent

Kangji Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 22, 2022

Investor sentiment improved over the past week

First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.12 in 1H 2020)

Investor sentiment improved over the past week

Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.31 in FY 2019)

Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.31 in FY 2019)

Kangji Medical Holdings Limited to Report Fiscal Year 2020 Results on Mar 25, 2021

Investor sentiment deteriorated over the past week

New 90-day low: €1.15

New 90-day low: €1.27

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: €1.50

Market pulls back on stock over the past week

New 90-day low: €2.06

Kangji Medical Holdings Limited Appoints Frances Fang Chovanec as Executive Director

First half earnings released

Earnings released

Kangji Medical Holdings Limited to Report First Half, 2020 Results on Aug 25, 2020

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin